期刊文献+

环孢素联用伏立康唑致再生障碍性贫血患儿血压持续升高的药学监护 被引量:6

Pharmaceutical Care of Hypertension Induced by the Combination of Cyclosporine A and Voriconazole in A Child with Aplastic Anemia
在线阅读 下载PDF
导出
摘要 目的探讨临床药师参与药物相互作用引起不良反应处理的药学实践。方法分析1例再生障碍性贫血儿童联合使用环孢素(Cs A)与伏立康唑引起的高血压原因及处理。结果 Cs A可能导致患儿持续性高血压,除需进行Cs A剂量调整,必要时需使用降压药物治疗,在遴选降压药物时亦应考虑其与Cs A的药物相互作用。结论临床药师可以通过分析药物相互作用,参与药物相关性不良反应处理,体现在治疗团队中的价值。 ObjectiveTo investigate the pharmacy practice of clinical pharmacists'attendance in the treatment of adverse reactions caused by drug interactions.MethodsAnalysis was conducted on the causes and treatment of hypertension in one pedinatric patient with aplastic anemia induced by combined use of cyclosporine and voriconazole.ResultsCyclosporine A could lead to prolonged hypertension.Cyclosporine A dosage should be adjusted;antihypertensive drugs should be used in necessity.When choosing antihypertensive drugs,drug interaction with cyclosporine A should be considered.ConclusionClinical pharmacists could manage adverse drug reactions by analyzing drug interactions,and offer suggestions for ADR patients.
作者 吴劲东 仇锦春 张永 WU Jindong;QIU jinchun;ZHANG Yong(Women and Children's Hospital of Sanshui Foshan,Foshan 528100,China;Children's Hospital,Nanjing Medical University,Nanjing 210000,China)
出处 《医药导报》 CAS 2017年第12期1419-1421,共3页 Herald of Medicine
基金 南京市医学科技发展专项资金资助项目(YKK14112) 江苏省药学会-百特生物药学基金科研项目(201507)
关键词 环孢素A 伏立康唑 相互作用 药物 高血压 Cyclosporin A Voriconazole Interactions,drug Hypertension
作者简介 吴劲东(1986-),男,安徽佛山人,药师,硕士,主要从事小儿用药临床药学工作。电话:0757-87800916,E-mail:184810474@qq.com。;通信作者,张永(1980-),男,江苏南京人,主管药师,硕士,主要从事小儿用药临床药学工作。电话:025-83117533,E-mail:fusematic@163.com。
  • 相关文献

参考文献2

二级参考文献34

  • 1卢一平,沈宏,杨宇如,唐科仕,王莉.钙通道阻滞剂在肾移植术后早期应用的临床研究[J].华西医学,1996,11(4):483-486. 被引量:4
  • 2Drachenberg CB,Klassen DK,Weir MR,et al.Islet cell damage associated with tacrolimus and cyclosporine:morphological features in pancreas allograft biopsies and clinical correlation[J],Transplantation,1999,68(3):396-402.
  • 3Slobodan Rendic.Summary of information on hman CYP enzymes:hman P450 metabolism data[J].Drug Metabolism Reviews,2002,34(1-2),83-448.
  • 4El-Husseini A,El-Basuony F,Mahmoud I,et al.Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome[J].Eur J Clin Pharmacol,2006,62(1):3-8.
  • 5El-Husseini A,El-Basuony F,Donia A,et al.Co-admin istration of cyclosporine and ketoconazole in children with minimal change nephrotic syndrome[J].Nephron Clin Pract,2005,100(2):27-32.
  • 6El-Husseini A,el-Basuony F,Mahmoud I,et al.Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis[J].Pediatr Nephrol,2004,19 (9):976-981.
  • 7El-Agroudy AE,Sobh MA,Hamdy AF,et al.A prospective,randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients:ten-year follow-up[J].Transplantation,2004,77(9):1371 1371-1376.
  • 8Gerntholtz T,Pascoe MD,Botha JF,et al.The use of a cyclosporin-ketoconazol combination:making renal transplantation affordable in developing countries[J].Eur J Clin Pharmacol,2004,60(3):143-148.
  • 9Schmider J,Greenblatt DJ,VonMoltke LL,et al.Inhibi tion of cytochrome P450 by nefazodone in vitro:studies of dextromethorphan O-and N-demethylation[J].Br J Clin Pharmacol,1996,41:339-343.
  • 10Dominguez J,Kompatzki A,Foradori A,et al.Ketoconazole alters cyclosporine pharmacokinetic profile and may predispose to acute rejection[J].Transplant Proc,2003,35(7):2522-3.

共引文献10

同被引文献45

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部